Should I buy Intuitive Surgical (ISRG) stock or is it too late?
⭐ The most reliable of them, either direction: Bernstein — 69% of its targets hit on this sector (70 calls tested). It aims for $685 (+62 %), call made on July 18, 2026, maturing on July 18, 2027 (88 d ago).
Firm-by-firm track record on Intuitive Surgical
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Raymond James | 82 % | +31.0 % | 22 | $483 +14% |
| Barclays | 92 % | +26.3 % | 12 | $485 +15% |
| Truist Securities | 71 % | +24.6 % | 21 | $510 +21% |
| Stifel | 88 % | +24.6 % | 17 | $550 +30% |
| RBC Capital | 60 % | +22.2 % | 15 | $575 +36% |
| Goldman Sachs | 60 % | +20.6 % | 5 | $609 +44% |
| Wells Fargo | 61 % | +20.5 % | 23 | $487 +15% |
| JP Morgan | 69 % | +20.0 % | 13 | $450 +7% |
✅ Reasons to believe
- 85% of analysts rate it a buy (Buy consensus, 20 ratings) — a sign of market conviction.
- Median price target $494, i.e. +17% from the current price ($422).
- The most reliable firm on ISRG, Bernstein (100% hit rate, 3 scored calls), targets $685 (call made on July 17, 2026, maturing on July 17, 2027) (+62%) in its most recent call, and $740 (call made on January 9, 2026, maturing on January 9, 2027) (+75%) in the one coming due soonest.
- 14 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 20 ratings, 3 are neutral.
- High valuation (P/E ~48): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on ISRG
Median target $494 (+17%) · 20 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Intuitive Surgical now?
We won't decide for you. The facts: 85% of analysts rate it a buy, median target $494 (+17%), and Bernstein (most reliable on ISRG, 100%) targets $685. Weigh that against valuation (P/E ~48). This is not personalized advice.
Is it too late to invest in Intuitive Surgical?
Not according to analysts: the median target ($494) is still +17% above the current price ($422) (most reliable on ISRG: Bernstein, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Intuitive Surgical still worth investing in?
It depends on the gap between the price ($422) and its estimated value: analysts target $494 on median (+17%), with 85% buys (most reliable on ISRG: Bernstein, 100%). Cross-check with their real reliability on ISRG and the cautions above. Information, not advice.
What's the main risk in buying ISRG?
The consensus is not unanimous: of 20 ratings, 3 are neutral.
→ Go deeper: the full Intuitive Surgical profile (consensus, analyst reliability, price target, performance).